annual EBITDA:
-$537.61M+$113.68M(+17.46%)Summary
- As of today (July 4, 2025), VIR annual EBITDA is -$537.61 million, with the most recent change of +$113.68 million (+17.46%) on December 31, 2024.
- During the last 3 years, VIR annual EBITDA has fallen by -$964.17 million (-226.03%).
- VIR annual EBITDA is now -164.01% below its all-time high of $839.85 million, reached on December 31, 2022.
Performance
VIR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$136.69M-$18.48M(-15.64%)Summary
- As of today (July 4, 2025), VIR quarterly EBITDA is -$136.69 million, with the most recent change of -$18.48 million (-15.64%) on March 31, 2025.
- Over the past year, VIR quarterly EBITDA has dropped by -$61.08 million (-80.78%).
- VIR quarterly EBITDA is now -113.46% below its all-time high of $1.02 billion, reached on March 31, 2022.
Performance
VIR quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$598.69M-$61.08M(-11.36%)Summary
- As of today (July 4, 2025), VIR TTM EBITDA is -$598.69 million, with the most recent change of -$61.08 million (-11.36%) on March 31, 2025.
- Over the past year, VIR TTM EBITDA has dropped by -$9.52 million (-1.61%).
- VIR TTM EBITDA is now -137.44% below its all-time high of $1.60 billion, reached on March 31, 2022.
Performance
VIR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VIR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.5% | -80.8% | -1.6% |
| 3 y3 years | -226.0% | -113.5% | -137.4% |
| 5 y5 years | -209.9% | -93.6% | -188.7% |
VIR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -164.0% | +17.5% | -169.5% | +38.9% | -138.3% | +10.7% |
| 5 y | 5-year | -164.0% | +17.5% | -113.5% | +38.9% | -137.4% | +10.7% |
| alltime | all time | -164.0% | +17.5% | -113.5% | +38.9% | -137.4% | +10.7% |
VIR EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$136.69M(+15.6%) | -$598.69M(+11.4%) |
| Dec 2024 | -$537.61M(-17.5%) | -$118.21M(-45.2%) | -$537.61M(-2.1%) |
| Sep 2024 | - | -$215.70M(+68.4%) | -$549.12M(+7.2%) |
| Jun 2024 | - | -$128.09M(+69.4%) | -$512.20M(-13.1%) |
| Mar 2024 | - | -$75.61M(-41.7%) | -$589.17M(-9.5%) |
| Dec 2023 | -$651.29M(-177.5%) | -$129.72M(-27.4%) | -$651.29M(-2.8%) |
| Sep 2023 | - | -$178.77M(-12.8%) | -$670.13M(+127.4%) |
| Jun 2023 | - | -$205.07M(+48.9%) | -$294.71M(-5.9%) |
| Mar 2023 | - | -$137.73M(-7.3%) | -$313.26M(-137.3%) |
| Dec 2022 | $839.85M(+96.9%) | -$148.55M(-175.5%) | $839.85M(-46.2%) |
| Sep 2022 | - | $196.65M(-187.9%) | $1.56B(+18.9%) |
| Jun 2022 | - | -$223.63M(-122.0%) | $1.31B(-17.9%) |
| Mar 2022 | - | $1.02B(+77.1%) | $1.60B(+274.9%) |
| Dec 2021 | $426.56M | $573.27M(-1204.6%) | $426.56M(-268.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$51.90M(-183.1%) | -$253.78M(-11.9%) |
| Jun 2021 | - | $62.42M(-139.7%) | -$288.06M(-23.8%) |
| Mar 2021 | - | -$157.23M(+46.9%) | -$378.17M(+29.7%) |
| Dec 2020 | -$291.54M(+68.1%) | -$107.06M(+24.2%) | -$291.54M(+18.0%) |
| Sep 2020 | - | -$86.19M(+211.3%) | -$247.07M(+19.2%) |
| Jun 2020 | - | -$27.68M(-60.8%) | -$207.35M(-3.2%) |
| Mar 2020 | - | -$70.60M(+12.8%) | -$214.31M(+23.5%) |
| Dec 2019 | -$173.46M(+49.6%) | -$62.59M(+34.7%) | -$173.46M(+26.8%) |
| Sep 2019 | - | -$46.47M(+34.2%) | -$136.76M(+10.4%) |
| Jun 2019 | - | -$34.64M(+16.4%) | -$123.90M(+38.8%) |
| Mar 2019 | - | -$29.76M(+14.9%) | -$89.26M(+50.0%) |
| Dec 2018 | -$115.94M(+43.0%) | -$25.90M(-22.9%) | -$59.50M(+77.1%) |
| Sep 2018 | - | -$33.60M | -$33.60M |
| Dec 2017 | -$81.06M | - | - |
FAQ
- What is Vir Biotechnology annual EBITDA?
- What is the all time high annual EBITDA for Vir Biotechnology?
- What is Vir Biotechnology annual EBITDA year-on-year change?
- What is Vir Biotechnology quarterly EBITDA?
- What is the all time high quarterly EBITDA for Vir Biotechnology?
- What is Vir Biotechnology quarterly EBITDA year-on-year change?
- What is Vir Biotechnology TTM EBITDA?
- What is the all time high TTM EBITDA for Vir Biotechnology?
- What is Vir Biotechnology TTM EBITDA year-on-year change?
What is Vir Biotechnology annual EBITDA?
The current annual EBITDA of VIR is -$537.61M
What is the all time high annual EBITDA for Vir Biotechnology?
Vir Biotechnology all-time high annual EBITDA is $839.85M
What is Vir Biotechnology annual EBITDA year-on-year change?
Over the past year, VIR annual EBITDA has changed by +$113.68M (+17.46%)
What is Vir Biotechnology quarterly EBITDA?
The current quarterly EBITDA of VIR is -$136.69M
What is the all time high quarterly EBITDA for Vir Biotechnology?
Vir Biotechnology all-time high quarterly EBITDA is $1.02B
What is Vir Biotechnology quarterly EBITDA year-on-year change?
Over the past year, VIR quarterly EBITDA has changed by -$61.08M (-80.78%)
What is Vir Biotechnology TTM EBITDA?
The current TTM EBITDA of VIR is -$598.69M
What is the all time high TTM EBITDA for Vir Biotechnology?
Vir Biotechnology all-time high TTM EBITDA is $1.60B
What is Vir Biotechnology TTM EBITDA year-on-year change?
Over the past year, VIR TTM EBITDA has changed by -$9.52M (-1.61%)